Cholesterol-lowering drugs also may protect stem cell transplant patients from graft-versus-host disease
Friday, December 4, 2009 - 15:28
in Health & Medicine
Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the US. Now a new study indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD.